Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Interventional × inebilizumab × Clear all

Phase

Status

Completed 5 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

pembrolizumab 368 Carboplatin 266 Cyclophosphamide 257 Nivolumab 248 Paclitaxel 210 Cisplatin 201 Specimen Handling 196 Magnetic Resonance Spectroscopy 195 Radiotherapy 177 Dexamethasone 157 Gemcitabine 152 durvalumab 148 Biopsy 139 atezolizumab 131 Lenalidomide 121 Rituximab 116 Doxorubicin 115 Docetaxel 113 Bevacizumab 113 Ipilimumab 107 Radiosurgery 98 Radiation 98 Oxaliplatin 98 Capecitabine 98 fludarabine 96 Fluorouracil 94 Etoposide 94 venetoclax 93 Prednisone 93 Pemetrexed 89

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04524273 2026-03-10

MINT

Amgen

Phase 3 Active not recruiting

238 enrolled 36 charts

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡